SEC Scores Partial Win In Insider Trading Case Over 2009 Sanofi (France) Deal

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Federal securities regulators have won a partial victory against two brothers accused of trading on inside information in 2009 about French pharmaceutical company Sanofi’s plan to buy a Tennessee-based company. A jury in the U.S. district court in Cleveland, Ohio, found that Andrew Jacobs and Leslie Jacobs committed insider trading in the context of a tender offer, the U.S. Securities and Exchange Commission announced in a statement. At the same time, the jury also found that the brothers were not liable under a broader insider trading statute not specific to tender offers, Ned Searby, a lawyer for Leslie Jacobs, said.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC